Note: Ingredients listed on restricted chemical lists
EC/CAS
200-015-4/50-18-0
Name of the chemical
Cyclophosphamide (INN) and its salts
Concentration
N/A
EC/CAS
200-015-4/9005-25-8
Name of the chemical
Starch
Concentration
5-15
EC/CAS
238-877-9/14807-96-6
Name of the chemical
Talc
Concentration
5-15
EC/CAS
200-334-9/57-50-1
Name of the chemical
Sucrose, pure C12H22O11
Concentration
7-18
EC/CAS
13463-67-7
Name of the chemical
Reaction mass of titanium dioxide and silver chloride
Concentration
01-211948937
EC/CAS
25322-68-3
Name of the chemical
polyethyleneglycol
Concentration
01-211995880
EC/CAS
231-545-4/7631-86-9
Name of the chemical
Silver adsorbed on silicon dioxide
Concentration
01-211937949
EC/CAS
232-679-6
Name of the chemical
Starch
Concentration
5-15
EC/CAS
236-675-5
Name of the chemical
Titandioxid; [in Pulverform mit mindestens 1 % Partikel mit aerodynamischem Durchmesser ≤ 10 μm] (2020/217)
Concentration
15-30
EC/CAS
207-439-9
Name of the chemical
Calcium carbonate
Concentration
9-17
General Information
Revision date
2024-04-23
Product name
Cyclophosphamide Tablets
Product Synonyms
Endoxan Tablets
1.2.1 Relevant identified uses
Antineoplastic Agent
Emergency telephone
+1 760 476 3962
Icons in SDS
Company Information
company name
BAXTER HEALTHCARE CORPORATION
e-mail address of the competent person responsible for the Safety Data Sheet
medinfo_emea@baxter.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H302, H315, H317, H318, H340, H350, H360, H362, H372
Hazard statements
Code
Statements
H302
Harmful if swallowed
Section 2
SECTION 2: Hazards identification
Regulation (EC) No. 1272/2008 Classification of the substance or mixture
Contains
Cyclophosphamide, Titanium Dioxide 0 % of components with unknown hazards to the aquatic environment
Signal word
Danger
Hazard statements
H302 - Harmful if swallowed H315 - Causes skin irritation H317 - May cause an allergic skin reaction H318 - Causes serious eye damage H340 - May cause genetic defects H350 - May cause cancer H360 - May damage fertility or the unborn child H362 - May cause harm to breast-fed children H372 - Causes damage to organs through prolonged or repeated exposure
Precautionary statements
P201 - Obtain special instructions before use. P260 - Do not breathe dust/fume/gas/mist/vapors/spray. P263 - Avoid contact during pregnancy and while nursing. P280 - Wear protective gloves/protective clothing/eye protection/face protection. P305 + P351 + P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P310 - Immediately call a POISON CENTER or doctor. Unknown acute toxicity 25.108 % of the mixture consists of ingredient(s) of unknown acute oral toxicity. 82.175 % of the mixture consists of ingredient(s) of unknown acute dermal toxicity. 97.011 % of the mixture consists of ingredient(s) of unknown acute inhalation toxicity (gas). 97.011 % of the mixture consists of ingredient(s) of unknown acute inhalation toxicity (vapor). 97.011 % of the mixture consists of ingredient(s) of unknown acute inhalation toxicity (dust/mist). Unknown aquatic toxicity
Additional information
This product requires child resistant fastenings if supplied to the general public. This product requires tactile warnings if supplied to the general public.
2.3 Other hazards
No information available. Endocrine Disruptor Information This product does not contain any known or suspected endocrine disruptors. Chemical name
2.1 Classification of the substance or mixture
Regulation (EC) No 1272/2008 Acute toxicity - Oral Category 4 - (H302) Skin corrosion/irritation Category 2 - (H315) Serious eye damage/eye irritation Category 1 - (H318) Skin sensitization Category 1 - (H317) Germ cell mutagenicity Category 1A - (H340) Carcinogenicity Category 1A - (H350) Reproductive toxicity Category 1A - (H360) Effects on or via lactation Yes - (H362) Specific target organ toxicity (repeated exposure) Category 1 - (H372)
